370 filings
Page 9 of 19
D
1chil3yx1dcouc4w1a
13 Apr 20
$52.37M in equity, sold $52.37M, 58 investors
12:00am
D
z2rb7az3a1gjxremz
13 Apr 20
$19.68M in equity, sold $19.68M, 5 investors
12:00am
8-K
86ehq86e81 bd
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
d768h6mtr32toyyvte
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
fbh7b5li2lexq3k
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
2hcjokvlx5b
1 Apr 20
Regulation FD Disclosure
4:39pm
8-K
1jmr8
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
S-3ASR
vbb3qq8ht1lyvg 80
18 Mar 20
Automatic shelf registration
10:00pm
8-K/A
sfaca1scu
16 Mar 20
Completion of Acquisition or Disposition of Assets
5:18pm
S-8
8milh0 ze7
11 Mar 20
Registration of securities for employees
12:00am
8-K
vhe5d
10 Mar 20
Invitae to Acquire YouScript and Genelex to Make it Easier to Use Pharmacogenetic Information at the Point of Care
4:33pm
S-8
c13fb
28 Feb 20
Registration of securities for employees
9:43pm
8-K
068likenmj kzjqhd
19 Feb 20
Invitae Reports $216.8 Million in Annual Revenue Driven by More Than 482,000 Samples in 2019
4:08pm
8-K
wgndur
13 Jan 20
Results of Operations and Financial Condition
5:11pm
S-3ASR
gdrdbh
18 Nov 19
Automatic shelf registration
5:18pm
8-K
vhklp 8m5i5kw
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
8-K
btrjvdi
6 Nov 19
Invitae Reports $56.5 Million in Quarterly Revenue Driven by 129,000 Samples
4:08pm
8-K/A
jbs7r8e3hfmp 6cy6ry5
27 Sep 19
Financial Statements and Exhibits
4:16pm